TScan Therapeutics TCRX
NASDAQ TCRX
$0.32 +0.00 (+0.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

TScan Therapeutics (TCRX) Interest Expenses (2022 - 2026)

Updated

TScan Therapeutics (TCRX) posted Interest Expenses of $699,000 for Q2 2026, up 1.5% from $689,000 a year earlier and up 1.5% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Interest Expenses (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest Expenses at TScan Therapeutics was $2.79 million, down 10.3% year-over-year; for FY2025, it came in at $2.77 million, down 24.2% from FY2024.

  • Annual Interest Expenses shows a three-year compound annual growth rate of 33.0% (FY2022 to FY2025).
  • In prior years, TScan Therapeutics' Interest Expenses was $3.65 million in FY2024 (-2.8%), $3.76 million in FY2023 (+219.6%) and $1.18 million in FY2022.
  • Quarterly Interest Expenses has run from a low of $201,000 in Q3 2022 to a high of $982,000 in Q3 2023 over five years.
  • On a year-over-year basis, Interest Expenses increased in two of the last eight quarters, with an average decline of 12.7%.
  • The strongest year-over-year quarter for Interest Expenses in the past five years was Q3 2023, with growth of 388.6%; the weakest was Q1 2025, with a decline of 29.2%.
  • According to Business Quant data, Interest Expenses for the three prior quarters was $689,000 (Q1 2026), $702,000 (Q4 2025) and $699,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 TScan Therapeutics 40.28 Mn 40.28 Mn - 699,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 699,000.00
Mar 31, 2026 689,000.00
Dec 31, 2025 702,000.00
Sep 30, 2025 699,000.00
Jun 30, 2025 689,000.00
Mar 31, 2025 679,000.00
Dec 31, 2024 784,000.00
Sep 30, 2024 958,000.00
Jun 30, 2024 952,000.00
Mar 31, 2024 959,000.00
Dec 31, 2023 852,000.00
Sep 30, 2023 982,000.00
Jun 30, 2023 969,000.00
Mar 31, 2023 956,000.00
Dec 31, 2022 975,000.00
Sep 30, 2022 201,000.00
API Access

TScan Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=TCRX&period=max&api_key=YOUR_API_KEY